BIOC Stock UPDATES Biocept Inc (BIOC) 2.98 10/22/2014 11:38:

New Post Public Reply Private Reply Replies (0) Message Board

Oct 22, 2014 at 12:38 PM

Biocept Inc (BIOC) 2.98 $BIOC

Biocept and Rosetta Genomics Collaborate to Evaluate microRNAs From Circulating Tumor Cells
GlobeNewswire - Mon Oct 13, 7:30AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (cfDNA) and circulating tumor cells (CTCs), and Rosetta Genomics, Ltd. (Nasdaq:ROSG), a leading molecular diagnostics company advancing microRNA-based diagnostics based on its proprietary microRNA platform technologies, today announced a collaboration that will combine both companies' platform technologies in an innovative approach to cancer diagnostics. The collaboration will utilize Biocept's patented microfluidic channel technology to capture CTCs and then apply Rosetta Genomics' technical expertise and proprietary methods to extract and analyze microRNA from these cells. The companies will test for markers currently offered by Rosetta as well as pursue new potential markers.
ROSG: 2.95 (-0.07), BIOC: 2.98 (+0.14)

Market Maker Surveillance Report. ISSC, CBK, ANV, BIOC, OMAG, TCS, Losing Stocks With Lowest Price Friction For Tuesday, October 7th 2014
M2 - Wed Oct 08, 4:24AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4746 companies with "abnormal" market making, 1204 companies with positive Friction Factors and 3932 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Innovative Solutions and Support Inc (NASDAQ:ISSC), Christopher & Banks Corp (NYSE:CBK), Allied Nevada Gold Corp (NYSE:ANV), BioClinica Inc (NASDAQ:BIOC), Omagine Inc (OTC:OMAG), (NYSE:TCS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
ANV: 2.36 (-0.10), CBK: 6.37 (-0.02), ISSC: 2.67 (-0.05), TCS: 17.27 (-0.05), BIOC: 2.98 (+0.14)

Nasdaq stocks posting largest volume increases
AP - Tue Oct 07, 6:00PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
DRTX: 24.00 (-0.09), GTAT: 0.44 (+0.03), LPHI: 1.90 (-0.01), ISSC: 2.67 (-0.05), ADHD: 5.37 (+0.25), LAKE: 13.84 (-1.10), STRN: 5.02 (-0.03), SNSS: 1.43 (-0.04), GTWN: 16.14 (-0.11), BIOC: 2.98 (+0.14), ELTK: 1.59 (+0.03)

Biocept Expands Collaboration With MD Anderson Cancer Center
GlobeNewswire - Tue Oct 07, 7:39AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced the furthering of its collaboration with The University of Texas MD Anderson Cancer Center regarding studies focused on patients diagnosed with ovarian cancer.
BIOC: 2.98 (+0.14)

Biocept to Present at the 13th Annual BIO Investor Forum
GlobeNewswire - Tue Sep 30, 7:31AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating tumor DNA (ctDNA), today announced that Michael Nall, Biocept President and CEO, is scheduled to present a corporate overview at the 13 Annual BIO Investor Forum on October 7, 2014 at The Palace Hotel in San Francisco.
BIOC: 2.98 (+0.14)

Biocept Granted Patent in China for Its Microfluidic Channel Technology Used to Capture Circulating Tumor Cells
GlobeNewswire - Thu Sep 18, 9:34AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) biomarker analysis, today announced that the Company has been granted a patent in China for its microfluidic channel technology used to capture CTCs. The granted patent is the subject of Chinese Patent No. ZL200780032530.2, entitled, "Detection or Isolation of Target Molecules Using a Microchannel Apparatus."
BIOC: 2.98 (+0.14)

Biocept to Present at Upcoming Investor Conferences
GlobeNewswire - Thu Sep 04, 7:36AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) biomarker analysis, today announced that Michael Nall, Biocept President and CEO, will be presenting a corporate overview at the following upcoming investor conferences:
BIOC: 2.98 (+0.14)

Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe
GlobeNewswire - Wed Sep 03, 7:30AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) biomarker analysis, today announced that the opposition period has expired for challenging the validity of its European Patent No. 1838442, entitled, "Cell Separation Using Microchannel Having Patterned Posts." This patent supports the proprietary microfluidics blood-based technology Biocept uses to capture CTCs.
BIOC: 2.98 (+0.14)

Biocept Provides Second Quarter Operational Update
GlobeNewswire - Thu Aug 14, 7:31AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) biomarker analysis, today provided a business update following the recent filing with the US Securities and Exchange Commission of its Quarterly Report on Form 10-Q for the second quarter ended June 30, 2014.
BIOC: 2.98 (+0.14)

Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy
GlobeNewswire - Wed Aug 06, 7:43AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) biomarker analysis, today announced that Amy McNeal has joined the Company as Senior Director of Managed Care and Reimbursement Strategies.
DGX: 61.54 (+0.42), BIOC: 2.98 (+0.14)

Nasdaq stocks posting largest percentage decreases
AP - Fri Jun 27, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BIOC: 2.98 (+0.14), WAYN: 12.60 (-0.37), NYNY: 6.61 (-0.03), PTIE: 4.13 (-0.07)

Virobay Announces The Appointment Of James Welch As Chief Financial Officer
PR Newswire - Wed Jun 25, 11:00AM CDT
Virobay, Inc., a clinical stage pharmaceutical company with a broad platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune diseases and fibrosis, today announced the appointment of James Welch as Chief Financial Officer, effective as of June 20, 2014.
BIOC: 2.98 (+0.14)

5 Stocks Setting Up to Break Out
at The Street - Mon Jun 23, 8:37AM CDT
These stocks look poised to break out and trade higher from current level.s
VLRS: 7.72 (-0.04), IDRA: 2.40 (+0.02), NVAX: 4.96 (-0.03), OHRP: 7.15 (-0.18), MDRX: 13.60 (+0.14), BIOC: 2.98 (+0.14)

5 Stocks Poised for Breakouts
at The Street - Fri Jun 13, 12:22PM CDT
These stocks look ready to break out and trade higher from current levels.
MNGA: 1.05 (unch), SCTY: 55.42 (-0.31), HEB: 0.32 (+0.01), VVUS: 3.39 (-0.08), CYTR: 2.69 (-0.07), BIOC: 2.98 (+0.14)

Biocept Appoints Commercialization Leader to Implement Global Diagnostic Sales Program
GlobeNewswire - Mon Mar 24, 10:30AM CDT
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) and biomarker analysis, today announced that it has appointed Raaj Trivedi as Vice President - Commercial Operations.
BIOC: 2.98 (+0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Porte Brown Hits #3 for Young Accountants in 2026

Fresh Faces Rank Porte Brown High Now here's a thing most big-name firms might envy—Porte Brown nabbed the #3 spot on Accounting Today's 2026 list of Best Firms for Young Accountants. This isn't some fly-by-night recognition; it speaks to their whole gig—nurturing, training, and growing young talent in the world of numbers. When you talk about setting the bar for...

Bit Digital Shifts Focus: Q3 2026 Sees Strategic Moves

Bit Digital's Strategic Shakeup Ah, the digital gold rush is heating up again. Bit Digital, the outfit focused on Ethereum strategies and AI, dropped their financial results for Q3 2026. Picture a company at a strategic crossroads, shedding bitcoin mining baggage to grab hold of fresh opportunities in Ethereum staking and AI infrastructure. Bit Digital's earnings paint a...

Lululemon Lawsuit Looms: Investors Face Key Decisions

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

Dexter Bowling BVL Event Series Honors Veterans

A Humble Roll to Honor Service Now, here's a heartwarming tale to chew over your morning coffee: Dexter Bowling is teaming up with the Bowlers to Veterans Link (BVL) for some feel-good festivities this holiday season. Beginning December, four special bowling events are rolling out across the U.S., designed just for veterans to connect over the camaraderie of spare strikes...

HSG Laser Boosts EU Presence with Düsseldorf Showroom

HSG Laser Makes a Bold Move in Europe When you're ripping off the band-aid and just diving into the hard truth, it's no small potatoes that HSG Laser has kicked open the doors to a shiny new showroom in Düsseldorf, Germany. This ain't just another brick in the wall—it's a sprawling 2,000 m² facility that marks a 20-year track record of tackling the European sector...

Kargo's Tech Boosts Profit on Seafood Supply Chain

Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...

tZERO Gains CFTC Approval, Paves Derivatives Path

Breaking into New Territory: tZERO's CFTC Triumph tZERO just scored a touchdown in the financial arena with its newly minted approval from the Commodity Futures Trading Commission. This green light allows them to dive into derivatives trading and clearing, a colossal leap for their Infrastructure-as-a-Service model. You could almost feel the corporate chest-thumping as...

Global Youth Co-Creation Plan Inspires Deep Living

Rediscovering Authenticity in a Fast-Paced World In a world obsessed with snappy content and instant fame, it's refreshing to see an initiative like the Global Youth Image Co-creation Plan take center stage. Unveiled at the third Hong Kong Night, the plan isn't just another flash in the pan. No, it's a call—practically a rallying cry—for young creators worldwide to...

Oman's Hydrogen Expansion: New Projects, Big Ambitions

Oman's Green Hydrogen Strategy Takes Bold Steps Say what you will about Oman, they fancy themselves as the green hydrogen pioneers of the future. Here’s the kicker: they’ve just awarded two heavy-hitting green hydrogen projects in Duqm, and they’re not stopping there. Announced at COP31, this is their third auction’s pièce de résistance, asserting Oman’s green...

M-tron Industries Delivers Robust Q3 2026 Performance

Key Takeaways from M-tron's Q3 Results Well, M-tron Industries just put out numbers for Q3 2026 that’ve got the street buzzing. With 11.1% growth in revenues, their top-line performance ain't something to sniff at, especially when the defense and aerospace sectors drive the engine. They're not just coasting on momentum—there's some solid guidance here, with a backlog...